Engineering Isoprenoid Biosynthesis Inartemisia Annual. for the Production of Taxadiene: A Key Intermediate of Taxol

Meiya Li,Fusheng Jiang,Xiangli Yu,Zhiqi Miao
DOI: https://doi.org/10.1155/2015/504932
2015-01-01
BioMed Research International
Abstract:Taxadiene is the first committed precursor to paclitaxel, marketed as Taxol, arguably the most important anticancer agent against ovarian and breast cancer. InTaxus, taxadiene is directly synthesized from geranylgeranyl diphosphate (GGPP) that is the common precursor for diterpenoids and is found in most plants and microbes. In this study,Artemisia annuaL., a Chinese medicinal herb that grows fast and is rich in terpenoids, was used as a genetic engineering host to produce taxadiene. TheTXS(taxadiene synthase) gene, cloned fromTaxusand inserted into pCAMBIA1304, was transformed intoArtemisia annuaL. using theAgrobacterium tumefaciens-mediated method. Thirty independent transgenic plants were obtained, and GC-MS analysis was used to confirm that taxadiene was produced and accumulated up to 129.7 μg/g dry mass. However, the high expression ofTXSdid not affect plant growth or photosynthesis in transgenicArtemisia annuaL. It is notable that artemisinin is produced and stored in leaves and most taxadiene accumulated in the stem of transgenicArtemisia annuaL., suggesting a new way to produce two important compounds in one transgenic plant: leaves for artemisinin and stem for taxadiene. Overall, this study demonstrates that genetic engineering of the taxane biosynthetic pathway inArtemisia annuaL. for the production of taxadiene is feasible.
What problem does this paper attempt to address?